Industry

Biotechnology

Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.

Total Companies
1 358
Biotechnology Industry
Company Intrinsic Valuation Profitability Score Solvency Score Market Cap
Abbvie Inc
NYSE:ABBV
Loading...
1% Undervalued
72 / 100
43 / 100
$385B
Amgen Inc
NASDAQ:AMGN
Loading...
10% Overvalued
64 / 100
29 / 100
$185.1B
Gilead Sciences Inc
NASDAQ:GILD
Loading...
23% Overvalued
66 / 100
65 / 100
$167.9B
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Loading...
22% Overvalued
59 / 100
87 / 100
$118B
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Loading...
3% Undervalued
57 / 100
97 / 100
$78.8B
CSL Ltd
ASX:CSL
Loading...
1% Undervalued
51 / 100
56 / 100
$59.5B
argenx SE
XBRU:ARGX
Loading...
40% Overvalued
58 / 100
99 / 100
$50.8B
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Loading...
24% Overvalued
50 / 100
48 / 100
$47.8B
Beigene Ltd
HKEX:6160
Loading...
23% Overvalued
38 / 100
78 / 100
$37.7B
Beigene Ltd
SSE:688235
Loading...
27% Overvalued
38 / 100
78 / 100
$37B
Insmed Inc
NASDAQ:INSM
Loading...
75% Overvalued
31 / 100
61 / 100
$34.1B
Natera Inc
NASDAQ:NTRA
Loading...
77% Overvalued
29 / 100
71 / 100
$33.9B
Celltrion Inc
KRX:068270
Loading...
40% Overvalued
49 / 100
69 / 100
$31.7B
BioNTech SE
NASDAQ:BNTX
Loading...
46% Overvalued
36 / 100
75 / 100
$28.6B
Biogen Inc
NASDAQ:BIIB
Loading...
18% Undervalued
53 / 100
65 / 100
$25.2B
Revolution Medicines Inc
NASDAQ:RVMD
Loading...
95% Overvalued
15 / 100
85 / 100
$22.6B
Genmab A/S
CSE:GMAB
Loading...
81% Overvalued
70 / 100
99 / 100
$20.5B
Incyte Corp
NASDAQ:INCY
Loading...
6% Undervalued
66 / 100
85 / 100
$20.1B
United Therapeutics Corp
NASDAQ:UTHR
Loading...
20% Overvalued
70 / 100
93 / 100
$20B
Exact Sciences Corp
NASDAQ:EXAS
Loading...
59% Overvalued
31 / 100
45 / 100
$19.4B
Load More